跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG
Fresenius Kabi Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 6, 2022
Approval ID
e2735c2e21c3ecc4
Company
Fresenius Kabi Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
e2735c2e21c3ecc4
Drug Cima Aemps Name
SUGAMMADEX FRESENIUS KABI 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
1221663001
Holder Company Name
Fresenius Kabi Deutschland Gmbh
Marketing Company Name
Fresenius Kabi España, S.A.U.
Holder Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Authorization Date
2022-10-06
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Fresenius Kabi Deutschland Gmbh
Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Fresenius Kabi Deutschland Gmbh
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.fresenius-kabi.com
Active Ingredients
SUGAMMADEX SODIO
108,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 6, 2022
Approval ID
e2735c2e21c3ecc4
Type
Standard
Back to CIMA-AEMPS Approvals